Portrai Inc.

Name: Portrai Inc.
Brand: Portrai Inc.

AI Native

Portrai is a spatial transcriptomics and machine learning company that provides a proprietary spatial transcriptomics database, analytics platform components, and project-based services for target discovery, biomarker development, mechanism-of-action analysis, and H&E-to-cell-type mapping.

Est 2021|Valuation $14.9M|Raised $14.5M

LinkedIn 550|Website|FTEs 19

01Competitive Landscape

Narrative analysis

Potential strengths of Portrai (subject to verification): - If dataset and model claims are accurate, the vendor-provided dataset could accelerate hypothesis generation compared with commissioning new experiments. - PortraiTME is presented as an H&E-to-spatial-mapping approach trained on spatial transcriptomic ground truth; vendor materials suggest it could be used as a preliminary screen in some contexts, but independent validation on target cohorts is required to confirm generalization. Competitor advantages: - Assay vendors (e.g., 10x Genomics) provide standardized platforms and community tools for generating primary spatial data. - Service vendors with a well-defined offering may provide clearer time-to-deliverables and integration guides for publication pipelines. Pricing comparison reality: - Portrai pricing is opaque. - Spatial experiments have material costs across vendors; published run and processing costs vary widely and can be substantial per run/slide depending on chemistry and institution, exclusive of downstream analysis.

	Portrai (vendor)	10x Genomics (Visium/Xenium)	Resolve Biosciences (Meridian service / Molecular Cartography)
Starting Price	Not publicly listed (quote-based)	Varies; many cores require quotes; some cores publish run costs	Not publicly listed (quote-based service)
Typical Use Case	Organizations seeking vendor-provided spatial oncology datasets plus analytics and services	Organizations generating primary spatial data on widely adopted platforms with ecosystem support	Teams seeking vendor-run high-resolution spatial services
Key Strengths	Vendor-claimed dataset scale; combined ST + AI pathology and modality-focused service offerings	Industry-standard assays and ecosystem; broad community adoption	High-resolution mapping and vendor-managed service pipeline
Key Weaknesses	Limited public third-party reviews; limited public security certification evidence; pricing and product boundaries are opaque	Cost and platform constraints; analysis burden	Pricing opacity; potential vendor lock-in depending on panels and workflows

01Competitive Landscape

Narrative analysis

Potential strengths of Portrai (subject to verification):

If dataset and model claims are accurate, the vendor-provided dataset could accelerate hypothesis generation compared with commissioning new experiments.
PortraiTME is presented as an H&E-to-spatial-mapping approach trained on spatial transcriptomic ground truth; vendor materials suggest it could be used as a preliminary screen in some contexts, but independent validation on target cohorts is required to confirm generalization.

Competitor advantages:

Assay vendors (e.g., 10x Genomics) provide standardized platforms and community tools for generating primary spatial data.
Service vendors with a well-defined offering may provide clearer time-to-deliverables and integration guides for publication pipelines.

Pricing comparison reality:

Portrai pricing is opaque.
Spatial experiments have material costs across vendors; published run and processing costs vary widely and can be substantial per run/slide depending on chemistry and institution, exclusive of downstream analysis.

	Portrai (vendor)	10x Genomics (Visium/Xenium)	Resolve Biosciences (Meridian service / Molecular Cartography)
Starting Price	Not publicly listed (quote-based)	Varies; many cores require quotes; some cores publish run costs	Not publicly listed (quote-based service)
Typical Use Case	Organizations seeking vendor-provided spatial oncology datasets plus analytics and services	Organizations generating primary spatial data on widely adopted platforms with ecosystem support	Teams seeking vendor-run high-resolution spatial services
Key Strengths	Vendor-claimed dataset scale; combined ST + AI pathology and modality-focused service offerings	Industry-standard assays and ecosystem; broad community adoption	High-resolution mapping and vendor-managed service pipeline
Key Weaknesses	Limited public third-party reviews; limited public security certification evidence; pricing and product boundaries are opaque	Cost and platform constraints; analysis burden	Pricing opacity; potential vendor lock-in depending on panels and workflows

Portrai Inc.

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map